Technology

Researchers have developed a new gene therapy approach that prevents the AIDS virus from entering human cells. The technique offers a potential way to treat HIV patients and could apply to any disease caused by a gene malfunction, including cancer. The research team created a new application for a genetic technology called small interfering RNA (siRNA). The synthetically designed siRNAs act as a catalyst to reduce the expression of specific genes and slow the progression of disease.

This year’s annual Monitoring the Future survey of American secondary school students provides much good news for the nation, reports the University of Michigan. Ecstasy use is finally beginning to decline among adolescents, the proportion using any illicit drug is also down, the proportion drinking alcohol has dropped, and the proportion reporting cigarette smoking continues to drop sharply.

A group of scientists have used a powerful laser in combination with innovative quantum mechanical computations to measure the flexibility of mouse antibodies. The new technique, described in an upcoming issue of the journal Proceedings of the National Academy of Sciences, is significant because protein flexibility is believed to play an important role in antibody — antigen recognition, one of the fundamental events in the human immune system. “This is the first time anybody has ever gone into a protein and experimentally measured the frequency of vibrations in response to an applied force,” said Floyd Romesberg, assistant professor in the Department of Chemistry at The Scripps Research Institute, who led the study.

Surgeons have developed new techniques for reconstructing the tongue during surgery for mouth cancer. The researchers found that the new methods often restore a patient’s ability to articulate speech and swallow normal food. The findings are published in the December issue of the Archives of Otolaryngology. “As surgeons, we are most concerned about removing all of the cancer, but we also want to preserve the person’s quality of life,” says lead author Bruce H. Haughey, M.D., associate professor of otolaryngology. “This work strives to improve both.”

The Bush Administration said it will ask Congress for legislation requiring drug companies to conduct pediatric clinical trials on new medicines. Clearer legislative authority is needed, instead of pursuing appeals in the courts, the administration believes. “The fastest and most decisive route for establishing clear authority in this area is to work with Congress for new legislation,” Secretary Tommy Thompson said. “Children are a special population that need to have access to drugs that can benefit them, and these drugs need to be properly tested for pediatric use, not prescribed and sold without testing. Congress alone can speak clearly on the authority that FDA needs and the provisions that may be appropriate for drug manufacturers when they are required to carry out these tests.”

It is commonplace for patients with Acute Lung Injury (ALI) to be injected with a dye, known as contrast material, before undergoing a CT (computerized tomography) scan of their lungs. Contrast material helps enhance the image so that doctors can evaluate the state of a patient?s lungs. New research published in Critical Care shows that using contrast material could worsen the condition of patients suffering from ALI because it causes the lungs to fill up with fluid, making it more difficult for patients to breathe.

HHS Secretary Tommy G. Thompson today invited all persons with questions about smallpox and the President’s vaccination plan to visit www.smallpox.gov for comprehensive and up-to-the-minute information. “This is a complicated issue that involves a careful balance between the possibility that smallpox might actually be released at some time by terrorists, and the known risks that are associated with the vaccine itself,” Secretary Thompson said. “I know from my own experience that this issue is complex and difficult, and we need to have answers easily available.”